| Names | |
|---|---|
|
Preferred IUPAC name
(3,4-Dihydroxyphenyl)acetaldehyde
|
|
| Other names
2-(3,4-Dihydroxyphenyl)acetaldehyde
Dopaldehyde |
|
| Identifiers | |
|
3D model (JSmol)
|
|
| 3DMet | B00668 |
| Abbreviations | DOPAL |
| ChEBI | |
| ChemSpider | |
| ECHA InfoCard | 100.237.172 |
| KEGG | |
| MeSH | 3,4-dihydroxyphenylacetaldehyde |
|
PubChem CID
|
|
|
|
|
|
| Properties | |
| C8H8O3 | |
| Molar mass | 152.15 g·mol−1 |
| Density | 1.306 g/mL |
| Boiling point | 351 °C (664 °F; 624 K) |
| Related compounds | |
|
Related 2-phenyl aldehydes
|
Phenylacetaldehyde |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
|
|
|
| Infobox references | |
3,4-Dihydroxyphenylacetaldehyde (DOPAL) is a metabolite of the neurotransmitter dopamine. DOPAL is an important precursor of the major brain metabolites of dopamine, 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxy-phenylacetic acid. DOPAL plays a role in Parkinson's disease. DOPAL has been chemically synthesized.